Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (‘Cardiol’ or the ‘Company’), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, is pleased to announce the Company has filed a preliminary prospectus supplement (the ‘Supplement’) to its…
The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) has traded at three-year highs in 2024 in response to looming interest rate cuts,…
Feneck laid out and discussed five points investors should consider when evaluating a junior mining company in order of…
Metals Australia Ltd (ASX: MLS) (“Metals Australia” or “the Company”) is pleased to announce that drilling is set to…
Boss Energy Limited (ASX: BOE|OTCQX: BQSSF) is pleased to announce that its 30 per cent-owned Alta Mesa ISR Uranium…
White Cliff Minerals Limited (“the Company”) is delighted to announce the first batch of assay results from rock chip…
Antilles Gold Limited (“Antilles Gold” or the “Company”) (ASX: AAU, OTCQB: ANTMF) advises that subsequent to the ASX announcement…
Alvopetro Energy Ltd. (TSXV: ALV) (OTCQX: ALVOF) announces September 2024 sales volumes and an operational update. President & CEO,…
Over the last six months, gold has been on an upward trajectory, registering fresh all-time highs nearly every month.…